Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF(TM) for the Management of Postoperative Pain for up to 72 Hours

ZYNRELEF, the first and only extended-release local anesthetic, is now available in distribution channels Heron has deployed new acute care sales representatives across the U.S. SAN DIEGO, July 1, 2021 -- (Healthcare Sales & Marketing Network) -- He... Biopharmaceuticals, Drug Delivery, Product Launch Heron Therapeutics, ZYNRELEF, bupivacaine, meloxicam
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news